Business Advisory Board

Rebiotix utilizes a world class business advisory board with breadth and depth knowledge in the pharmaceutical and biotechnology industry.

Mervyn J. Turner, PhD

  • 40 years of experience in pharmaceutical R&D, licensing, business and strategy development
  • Formerly Chief Strategy Officer, Merck & Co. Inc.

View Mervyn Turner’s complete bio

Sylvia McBrinn, MBA

  • 40 years experience with pharmaceutical and biotech companies in executive and general management, global and U.S. sales and marketing
  • CEO, President, Director and Founder Axerion Therapeutics, Inc.

View Sylvia McBrinn’s complete bio

Philip A. Gioia, MBA

  • 25 years of experience in leading commercial pharmaceutical operations including: acquisitions & integration, new business development, strategic planning & execution, portfolio management, sales and marketing
  • Formerly Global Head of Diversified Products and BD, Pharmaceuticals, Bausch and Lomb

View Philip A Gioia’s complete bio